529 related articles for article (PubMed ID: 30791837)
21. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
Wing AC; Kremenchutzky M
Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
[TBL] [Abstract][Full Text] [Related]
22. Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis.
Shamsaddini A; Gillevet PM; Acharya C; Fagan A; Gavis E; Sikaroodi M; McGeorge S; Khoruts A; Albhaisi S; Fuchs M; Sterling RK; Bajaj JS
Gastroenterology; 2021 Aug; 161(2):508-521.e7. PubMed ID: 33857456
[TBL] [Abstract][Full Text] [Related]
23. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.
Giannelli V; Di Gregorio V; Iebba V; Giusto M; Schippa S; Merli M; Thalheimer U
World J Gastroenterol; 2014 Dec; 20(45):16795-810. PubMed ID: 25492994
[TBL] [Abstract][Full Text] [Related]
24. Dynamic Properties of the Intestinal Ecosystem Call for Combination Therapies, Targeting Inflammation and Microbiota, in Ulcerative Colitis.
van de Guchte M; Mondot S; Doré J
Gastroenterology; 2021 Dec; 161(6):1969-1981.e12. PubMed ID: 34508776
[TBL] [Abstract][Full Text] [Related]
25. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature.
Giuffrè M; Campigotto M; Campisciano G; Comar M; Crocè LS
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G889-G906. PubMed ID: 32146836
[TBL] [Abstract][Full Text] [Related]
26. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.
Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM
Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
28. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic and Modulation of Microbiota: A New Paradigm?
Rizzatti G; Ianiro G; Gasbarrini A
J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S74-S77. PubMed ID: 29912755
[TBL] [Abstract][Full Text] [Related]
30. Disruption of the Gut Ecosystem by Antibiotics.
Yoon MY; Yoon SS
Yonsei Med J; 2018 Jan; 59(1):4-12. PubMed ID: 29214770
[TBL] [Abstract][Full Text] [Related]
31. Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair.
Tang TWH; Chen HC; Chen CY; Yen CYT; Lin CJ; Prajnamitra RP; Chen LL; Ruan SC; Lin JH; Lin PJ; Lu HH; Kuo CW; Chang CM; Hall AD; Vivas EI; Shui JW; Chen P; Hacker TA; Rey FE; Kamp TJ; Hsieh PCH
Circulation; 2019 Jan; 139(5):647-659. PubMed ID: 30586712
[TBL] [Abstract][Full Text] [Related]
32. Is irritable bowel syndrome an infectious disease?
Thompson JR
World J Gastroenterol; 2016 Jan; 22(4):1331-4. PubMed ID: 26819502
[TBL] [Abstract][Full Text] [Related]
33. Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
Berg D; Clemente JC; Colombel JF
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):781-95. PubMed ID: 25665875
[TBL] [Abstract][Full Text] [Related]
34. Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases.
Marietta E; Mangalam AK; Taneja V; Murray JA
Front Immunol; 2020; 11():573079. PubMed ID: 33193357
[TBL] [Abstract][Full Text] [Related]
35. Dysbiosis and Disease: Many Unknown Ends, Is It Time to Formulate Guidelines for Dysbiosis Research?
Veeranki S; Tyagi SC
J Cell Physiol; 2017 Nov; 232(11):2929-2930. PubMed ID: 27925191
[TBL] [Abstract][Full Text] [Related]
36. Does the buck stop with the bugs?: an overview of microbial dysbiosis in rheumatoid arthritis.
Sandhya P; Danda D; Sharma D; Scaria V
Int J Rheum Dis; 2016 Jan; 19(1):8-20. PubMed ID: 26385261
[TBL] [Abstract][Full Text] [Related]
37. Role of antibiotics for treatment of inflammatory bowel disease.
Nitzan O; Elias M; Peretz A; Saliba W
World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
[TBL] [Abstract][Full Text] [Related]
38. Dietary metabolism, the gut microbiome, and heart failure.
Tang WHW; Li DY; Hazen SL
Nat Rev Cardiol; 2019 Mar; 16(3):137-154. PubMed ID: 30410105
[TBL] [Abstract][Full Text] [Related]
39. A Comprehensive Review on Natural Bioactive Compounds and Probiotics as Potential Therapeutics in Food Allergy Treatment.
Pratap K; Taki AC; Johnston EB; Lopata AL; Kamath SD
Front Immunol; 2020; 11():996. PubMed ID: 32670266
[TBL] [Abstract][Full Text] [Related]
40. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
Distrutti E; Monaldi L; Ricci P; Fiorucci S
World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]